Cardiovascular Toxicology

Aims & Scope

Cardiovascular Toxicology is the only journal dedicated to publishing contemporary issues, timely reviews, and experimental and clinical data on toxicological aspects of cardiovascular disease.

CT publishes papers that will elucidate the effects, molecular mechanisms, and signaling pathways of environmental toxicants on the cardiovascular system.

Also covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy.

In addition, Cardiovascular Toxicology reports safety and toxicological data on new cardiovascular and non-cardiovascular drugs.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.7
2024	3.40

Journal Rank

Year	Value
2024	6381

Journal Citation Indicator

Year	Value
2024	762

SJR (SCImago Journal Rank)

Year	Value
2024	0.834

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	67

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The NF-κB Regulatory Network

  Citation: 432

  Authors: Allan R.

• Oxidative Stress and Diabetic Cardiomyopathy: A Brief Review

  Citation: 310

  Authors: Lu, Y James

• Role of anthracyclines in the era of targeted therapy

  Citation: 238

  Authors: Hernán, Cyntia

• Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches

  Citation: 175

  Authors: Mohammad, Yaser, Maryam, Sadaf, Faezeh, Mohammad Hadi, Ahmad Reza

• Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis

  Citation: 175

  Authors: Kendall B.

• Cell Death and Diabetic Cardiomyopathy

  Citation: 157

  Authors: Lu, Y. James

• Alcoholic Cardiomyopathy: Pathophysiologic Insights

  Citation: 155

  Authors: Mariann R., Shane A.

• Acrolein Can Cause Cardiovascular Disease: A Review

  Citation: 144

  Authors: Robert J., Giffe T., Jayme P., Raymond D.

• Arsenic Exposure and Cardiovascular Disorders: An Overview

  Citation: 137

  Authors: Pitchai, Jagdeep

• Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders

  Citation: 129

  Authors: Robert J., Marie, Raymond D.

---